Diana L. Moss

Diana Moss became the President of the American Antitrust Institute in January 2015. Since joining AAI in 2001, Dr. Moss has developed and expanded AAI’s advocacy channels and strategies, and strengthened communications with public and private enforcers, Congress, other advocacy groups, and the media. Her work spans both antitrust and regulation, with industry expertise in other areas.  From 1995 to 2001, Dr. Moss served in the Office of Economic Policy and Office of Markets, Tariffs, and Rates at the Federal Energy Regulatory Commission. There, she coordinated the agency’s economic analysis for electricity mergers and contributed to the development of the landmark open access rules. From 1989 to 1995, she consulted in private practice in the areas of regulation and antitrust. Dr. Moss is also Adjunct Faculty in the Department of Economics at the University of Colorado at Boulder.

Dr. Moss has spoken widely on various topics involving competition policy and enforcement, testified before Congress, appeared before state and federal regulatory commissions, at industry and academic conferences, and made numerous radio and television appearances. She has published articles in numerous economic and legal journals as well.

Dr. Moss was named to the GCR’s Women in Antitrust in 2016 and again in 2021.  In 2021, Dr. Moss was inducted into the American Bar Association Antitrust Law Section’s Hall of Fame-inism.  She holds a M.A. degree from the University of Denver and a Ph.D. from the Colorado School of Mines.

When AI Helps Generate Inventions, Who Is the Inventor?

By Andrei Iancu and Rama Elluru This commentary from the CSIS-SCSP Task Force on IP in the AI Era was originally published in the Special Competitive Studies Project’s Substack on February 15, 2024. With roots in the U.S. constitution, patent rights provide an exclusive property right in new inventions like drugs,
Read More

Standard Essential Patents and European Economic Security

By Kirti Gupta and Chris Borges On April 27, 2023, the European Commission published a draft proposal on standard essential patents (SEPs) seeking to address the perceived lack of transparency and predictability in the licensing of SEPs. The commission proposes the creation of a competence center within the European Union Intellectual
Read More

Proposed Federal Use of March-in Rights Would Weaken American Innovation

By Sujai Shivakumar and Thomas Howell   The Biden administration is considering exercising something called “march-in rights” as a policy prescription to curb drug prices. But as with any prescription, there is a need to weigh efficacy against the side-effects. In this case, there is evidence that the vast majority of
Read More